Our analysis of drug‐sensitive breast cancer cells indicated that MET inhibited cell proliferation and invasion by increasing the expression of the classical Hippo upstream regulators, KIBRA and FRMD6 (Figure 7A). This evidence concerns the gene FRMD6 and breast cancer.